RaQualia Pharma Inc. (TSE:4579) agreed to acquire FIMECS, Inc. from Nissay Capital No. 11 Investment Limited Partnership and Nissay Capital Co., Ltd. for ¥4.5 billion on February 14, 2024. The transaction is expected to close on March 26, 2024.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
638 JPY | +2.90% |
|
+6.33% | -7.27% |
![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-7.27% | 8.5Cr | |
+63.05% | 86TCr | |
+38.96% | 63TCr | |
-4.78% | 36TCr | |
+17.52% | 32TCr | |
+8.43% | 30TCr | |
+13.72% | 24TCr | |
+4.95% | 23TCr | |
+16.21% | 23TCr | |
+14.63% | 18TCr |
- Stock Market
- Equities
- 4579 Stock
- News RaQualia Pharma Inc.
- RaQualia Pharma Inc. agreed to acquire FIMECS, Inc. from Nissay Capital No. 11 Investment Limited Partnership and Nissay Capital Co., Ltd. for ¥4.5 billion.